The DOI matches its Crossref record; 214 of the 214 references it cites were found in a registry or an index.
Targeting receptor-mediated endocytotic pathways with nanoparticles: Rationale and advances
Open accessAbstract
Targeting of drugs and their carrier systems by using receptor-mediated endocytotic pathways was in its nascent stages 25 years ago. In the intervening years, an explosion of knowledge focused on design and synthesis of nanoparticulate delivery systems as well as elucidation of the cellular complexity of what was previously-termed receptor-mediated endocytosis has now created a situation when it has become possible to design and test the feasibility of delivery of highly specific nanoparticle drug carriers to specific cells and tissue. This review outlines the mechanisms governing the major modes of receptor-mediated endocytosis used in drug delivery and highlights recent approaches using these as targets for in vivo drug delivery of nanoparticles. The review also discusses some of the inherent complexity associated with the simple shift from a ligand-drug conjugate versus a ligand-nanoparticle conjugate, in terms of ligand valency and its relationship to the mode of receptor-mediated internalization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–214 of 214
Mechanistic Insights into LDL Nanoparticle-Mediated siRNA Delivery
Jin, H., Lovell, J. F., Chen, J., Lin, Q., Ding, L., Ng, K. K., Pandey, R. K., Manoharan, M., Zhang, Z., & Zheng, G. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200233n · Cited by 52
Barkey, N. M., Tafreshi, N. K., Josan, J. S., Silva, C. R. D., Sill, K., Hruby, V. J., Gillies, R. J., Morse, D. L., & Vágner, J. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201226w · Cited by 50
Hughes, J. B., Berger, C., Rødland, M. S., Hasmann, M., Stang, E., & Madshus, I. H. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0291 · Cited by 50
IGF-1 increases macrophage motility via PKC/p38-dependent αvβ3-integrin inside-out signaling
Furundzija, V., Fritzsche, J., Kaufmann, J., Meýborg, H., Fleck, E., Kappert, K., & Stawowy, P. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.072 · Cited by 44
Corbin, I. R., & Zheng, G. (2007) · Nanomedicine · doi:10.2217/17435889.2.3.375 · Cited by 40
Target drug delivery system as a new scarring modulation after glaucoma filtration surgery
Shao, T., Li, X., & Ge, J. (2011) · Diagnostic Pathology · doi:10.1186/1746-1596-6-64 · Cited by 38
Effects of Receptor Binding on Plasma Half-Life of Bifunctional Transferrin Fusion Proteins
Chen, X., Lee, H.-F., Zaro, J. L., & Shen, W. (2011) · Molecular Pharmaceutics · doi:10.1021/mp1003064 · Cited by 37
Membrane Transduction of Oligoarginine in HeLa Cells Is Not Mediated by Macropinocytosis
Zaro, J. L., Rajapaksa, T. E., Okamoto, C. T., & Shen, W. (2006) · Molecular Pharmaceutics · doi:10.1021/mp0500869 · Cited by 36
Self-citationComparison of FcRn‐ and pIgR‐Mediated Transport in MDCK Cells by Fluorescence Confocal Microscopy
Jerdeva, G. V., Tesar, D. B., Huey‐Tubman, K. E., Ladinsky, M. S., Fraser, S. E., & Björkman, P. J. (2010) · Traffic · doi:10.1111/j.1600-0854.2010.01083.x · Cited by 33
Big gulps: specialized membrane domains for rapid receptor-mediated endocytosis
McNiven, M. A. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.08.007 · Cited by 29
Hlavacek, W. S., Percus, J. K., Percus, O. E., Perelson, A. S., & Wofsy, C. (2002) · Mathematical Biosciences · doi:10.1016/s0025-5564(02)00091-3 · Cited by 25
Endocytosis of lipid-anchored proteins: excluding GEECs from the crowd
Nichols, B. J. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200907119 · Cited by 22
Mishra, S. K., Jha, A., Steinhauser, A. L., Kokoza, V. A., Washabaugh, C. H., Raikhel, A. S., Foster, W. A., & Traub, L. M. (2008) · Journal of Cell Science · doi:10.1242/jcs.025833 · Cited by 12
Norouziyan, F., Shen, W., & Hamm‐Alvarez, S. F. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00372.2006 · Cited by 7
Self-citation
Cited by
Innovative approaches for cancer treatment: current perspectives and new challenges
Pucci, C., Martinelli, C., & Ciofani, G. (2019) · ecancermedicalscience · doi:10.3332/ecancer.2019.961 · Cited by 814
Insight into nanoparticle cellular uptake and intracellular targeting
Yameen, B., Choi, W. I., Vilos, C., Swami, A., Shi, J., & Farokhzad, O. C. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.038 · Cited by 787
Controlled drug release from pharmaceutical nanocarriers
Lee, J. H., & Yeo, Y. (2015) · Chemical Engineering Science · doi:10.1016/j.ces.2014.08.046 · Cited by 628
Ginger‐derived nanoparticles protect against alcohol‐induced liver damage
Zhuang, X., Deng, Z., Mu, J., Zhang, L., Yan, J., Miller, D., Feng, W., McClain, C. J., & Zhang, H. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.28713 · Cited by 601
Cancer treatment therapies: traditional to modern approaches to combat cancers
Kaur, R., Bhardwaj, A., & Gupta, S. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08809-3 · Cited by 561
Metadata
- Authors
- Xu, S., Olenyuk, B. Z., Okamoto, C. T., & Hamm-Alvarez, S. F.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 65
- Issue
- 1
- Pages
- 121-138
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2066467291
- Cited by
- 467
- References
- 214
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.